Therapeutic Drug Monitoring of Adalimumab During Long-term Follow-up in Paediatric Patients With Crohn Disease.

Kim, Mi Jin; Kim, Eunsil; Kang, Ben; Choe, Yon Ho

Kim, Mi Jin; Kim, Eunsil; Kang, Ben; Choe, Yon Ho.

Afiliación

Kim MJ; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul.
Kim E; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul.
Kang B; Department of Pediatrics, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.
Choe YH; Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul.

J Pediatr Gastroenterol Nutr ; 72(6): 870-876, 2021 06 01.

Article en En | MEDLINE | ID: mdl-33908743

Asunto(s)

Enfermedad de Crohn; Adalimumab/uso terapéutico; Niño; Enfermedad de Crohn/tratamiento farmacológico; Monitoreo de Drogas; Estudios de Seguimiento; Humanos; Mucosa Intestinal; Estudios Prospectivos; Índice de Severidad de la Enfermedad

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedad de Crohn Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: J Pediatr Gastroenterol Nutr Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google